{"context":{"query":">>efo>>gwas_study","source_dataset":"efo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":28,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"EFO:0005952","source":"EFO:0005952|non-Hodgkins lymphoma","targets":["GCST90011819|Non-Hodgkin's lymphoma|Rashkin SR|Nat Commun|2020-09-04","GCST90025870|Non-hodgkin's lymphoma in HIV infection|Thorball CW|Haematologica|2020-07-16","GCST90041911|Cancer code, self-reported: non-hodgkins lymphoma (UKB data field 20001_1053)|Jiang L|Nat Genet|2021-11-04","GCST90042741|Non-Hodgkins lymphoma (PheCode 202.2)|Jiang L|Nat Genet|2021-11-04","GCST90043908|ICD10 C85.7: Other specified types of non-Hodgkin lymphoma|Jiang L|Nat Genet|2021-11-04","GCST90043909|ICD10 C85.9: Non-Hodgkin lymphoma, unspecified|Jiang L|Nat Genet|2021-11-04","GCST90077637|Non hodgkins lymphoma (UKB data field 20001)|Backman JD|Nature|2021-10-18","GCST90079121|Non-Hodgkin lymphoma (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079637|ICD10 C85.9: Non-Hodgkin lymphoma, unspecified|Backman JD|Nature|2021-10-18","GCST90079638|ICD10 C85: Other specified and unspecified types of non-Hodgkin lymphoma|Backman JD|Nature|2021-10-18","GCST90081623|Non hodgkins lymphoma (UKB data field 20001) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083107|Non-Hodgkin lymphoma (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083623|ICD10 C85.9: Non-Hodgkin lymphoma, unspecified (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083624|ICD10 C85: Other specified and unspecified types of non-Hodgkin lymphoma (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90246037|ICD10 C85.7: Other specified types of non-Hodgkin lymphoma|Walters RG|Cell Genom|2023-07-20","GCST90267403|Malignant lymphoma (Non-Hodgkin lymphoma, multiple myeloma, or Hodgkin lymphoma)|Berndt SI|Leukemia|2022-10-22","GCST90308759|Non-Hodgkin's lymphoma|Sato G|Nat Commun|2023-06-20","GCST90308764|Cancer|Sato G|Nat Commun|2023-06-20","GCST90435644|Non-Hodgkins lymphoma (PheCode 202.2)|Zhou W|Nat Genet|2018-08-13","GCST90477246|Non-Hodgkins lymphoma (PheCode 202.2)|Verma A|Science|2024-07-19","GCST90477247|Non-Hodgkins lymphoma (PheCode 202.2)|Verma A|Science|2024-07-19","GCST90479828|Non-Hodgkins lymphoma (PheCode 202.2)|Verma A|Science|2024-07-19","GCST90481537|Non-Hodgkins lymphoma (PheCode 202.2)|Verma A|Science|2024-07-19","GCST90651049|Non-Hodgkin's lymphoma|Sato G|Nat Commun|2023-06-20","GCST90651054|Cancer|Sato G|Nat Commun|2023-06-20","GCST90651064|Non-Hodgkin's lymphoma|Sato G|Nat Commun|2023-06-20","GCST90651069|Cancer|Sato G|Nat Commun|2023-06-20","GCST90651365|Non-Hodgkins lymphoma (PheCode 202.2)|Liu TY|Sci Adv|2025-06-04"]}]}